Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Dostarlimab 500, Tumor Biomarker Defined, Cycle 1-4

Protocol-ID: 2632 V1.0 (Mini), DOST500, Tumor Biomarker Defined, C1-4

Indication(s)

  • Tumor Biomarker Defined (Mismatch Repair - deficient / Microsatellite Instability - high (dMMR/MSI-H), POLE-altered)
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 07.06.2024